Lion's market integration play

The decision by Incyte Genomics Inc. to license SRS data integration software and seek customized solutions from Lion bioscience AG advances Lion's goal of making SRS the industry standard for data integration.

According to Mike Lack, COO at INCY, the deal will give the company's LifeSeq Foundation subscribers a choice between SRS from Lion (LEON, NMarkt:LIO, Heidelberg, Germany) and INCY's current data integration offering, which was co-developed with Secant Technologies Inc. (Cleveland, Ohio). LIO will receive annual license fees under the three-year agreement, plus sales royalties on the SRS-based platform...